Literature DB >> 35265417

Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin.

Tatsuaki Ishiguro1, Ryumei H Ishiguro1, Miyu Ishiguro1, Atsushi Toki2, Hiroshi Terunuma3.   

Abstract

We formerly reported that the combination of dichloroacetate, omeprazole, and tamoxifen blocked cancer progression by reducing lactic acid production and inducing superoxide production. Recently, ivermectin, a well-known anti-parasite drug, was reported to share the same mechanisms with them and have anti-tumor activity. Here, we present three patients in whom the combination of dichloroacetate, omeprazole (plus tamoxifen), and ivermectin dramatically relieved the symptoms accompanying cancer and sarcoma progression.
Copyright © 2022, Ishiguro et al.

Entities:  

Keywords:  cancer; dichloroacetate; ivermectin; omeprazole; sarcoma; tamoxifen

Year:  2022        PMID: 35265417      PMCID: PMC8898092          DOI: 10.7759/cureus.21884

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Authors:  Sébastien Bonnet; Stephen L Archer; Joan Allalunis-Turner; Alois Haromy; Christian Beaulieu; Richard Thompson; Christopher T Lee; Gary D Lopaschuk; Lakshmi Puttagunta; Sandra Bonnet; Gwyneth Harry; Kyoko Hashimoto; Christopher J Porter; Miguel A Andrade; Bernard Thebaud; Evangelos D Michelakis
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

3.  Use of oral dichloroacetate for palliation of leg pain arising from metastatic poorly differentiated carcinoma: a case report.

Authors:  Akbar Khan
Journal:  J Palliat Med       Date:  2011-04-12       Impact factor: 2.947

4.  Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage.

Authors:  Min Zhu; Youkong Li; Zhifang Zhou
Journal:  Biochem Biophys Res Commun       Date:  2017-08-25       Impact factor: 3.575

5.  Non-Hodgkin's Lymphoma Reversal with Dichloroacetate.

Authors:  Dana F Flavin
Journal:  J Oncol       Date:  2010-09-16       Impact factor: 4.375

6.  Cotreatment with dichloroacetate and omeprazole exhibits a synergistic antiproliferative effect on malignant tumors.

Authors:  Tatsuaki Ishiguro; Miyu Ishiguro; Ryumei Ishiguro; Sayuri Iwai
Journal:  Oncol Lett       Date:  2012-01-03       Impact factor: 2.967

7.  Efficacy of abamectin against natural infections of gastrointestinal nematodes and lungworm of cattle with special emphasis on inhibited, early fourth stage larvae of Ostertagia ostertagi.

Authors:  J C Williams; A F Loyacano; C Nault; R T Ramsey; R E Plue
Journal:  Vet Parasitol       Date:  1992-02       Impact factor: 2.738

8.  Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control study.

Authors:  A Wong; A Chan
Journal:  Cancer       Date:  1993-04-01       Impact factor: 6.860

9.  Cancer cell metabolism: Warburg and beyond.

Authors:  Peggy P Hsu; David M Sabatini
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

10.  Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.

Authors:  Angelo De Milito; Elisabetta Iessi; Mariantonia Logozzi; Francesco Lozupone; Massimo Spada; Maria Lucia Marino; Cristina Federici; Maurizio Perdicchio; Paola Matarrese; Luana Lugini; Anna Nilsson; Stefano Fais
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

View more
  1 in total

1.  Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells.

Authors:  Chun-Liang Tung; Wen-Ying Chao; Yi-Zhen Li; Cheng-Huang Shen; Pei-Wen Zhao; Shu-Hsin Chen; Tzu-Yun Wu; Ying-Ray Lee
Journal:  Int J Med Sci       Date:  2022-09-11       Impact factor: 3.642

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.